Casandra
Casandra Test Code PR97270Version 1 (DRAFT)
Performing Lab
Lab Prometheus LaboratoriesLab Test ID #3180
Anser VDZ
Clinical Use
Order TestUse
Anser VDZ supports the therapeutic drug monitoring of vedolizumab (VDZ) and antibodies-to-VDZ (ATV) levels. This aids in optimizing dosing for effective treatment outcomes in patients using vedolizumab, particularly in managing inflammatory disorders like IBD.
Special Instructions
Not provided.
Limitations
The Anser VDZ test remains a laboratory-developed procedure not sanctioned by the FDA. Its clinical application should be within the confines of CLIA-validated practices.
Test Details
Methodology
Immunoassay (HMSA)
Biomarkers
Result Turnaround Time
3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
2.0 mL
Minimum Volume
0.5 mL for Peds
Container
Serum Separator Tube or Red-Top Tube
Storage Instructions
Transport ambient or with a cold pack. Do not freeze.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
Similar Tests
Other tests from different labs that may be relevant
Vedolizumab and Anti-Vedolizumab Antibody, DoseASSURE™ VDZ
Labcorp
Vedolizumab Quantitation with Antibodies, Serum
ARUP Laboratories
Vedolizumab Quantitation with Antibodies, Serum
Mayo Clinic Lab
Certolizumab and Anti-Certolizumab Antibody, DoseASSURE™ CTZ
Labcorp
Certolizumab and Anti-Certolizumab Antibody, DoseASSURE CTZ
Mayo Clinic Lab
Adalimumab Drug Level and Anti‑drug Antibody for IBD
Quest Diagnostics
Infliximab Level and Anti‑drug Antibody for IBD
Quest Diagnostics
Ustekinumab Quantitation with Antibodies, Serum
ARUP Laboratories
Adalimumab Anti‑drug Antibody for IBD
Quest Diagnostics
Adalimumab and Anti-Adalimumab Antibody, DoseASSURE™ ADL
Labcorp